Why the study?
The predictors and clinical significance of increased Doppler-derived mean diastolic gradient following MVTEER remain controversial.
Does increased post-procedural mean gradient (>5 mmHg) after MVTEER increase subsequent mortality in patients undergoing MVTEER?
Does increased post-procedural mean gradient (>5 mmHg) after MVTEER increase subsequent mortality in patients undergoing MVTEER?
An increased mean diastolic gradient (>5 mmHg) following MVTEER is associated with significantly higher intermediate-term mortality, highlighting the importance of identifying patients at risk for iatrogenic mitral stenosis.
Elevated post-MVTEER MG was associated with higher mortality; leaves open whether avoiding it improves outcomes in small-MVA patients.
BACKGROUND: The predictors and clinical significance of increased Doppler-derived mean diastolic gradient (MG) following transcatheter edge-to-edge mitral valve repair (MVTEER) remain controversial. OBJECTIVE: We sought to examine baseline correlates of Doppler-derived increased MG post-MVTEER and its impact on intermediate-term outcomes. METHODS: Patients undergoing MVTEER were analyzed retrospectively. Post-MVTEER increased MG was defined as >5 mmHg or aborted clip implantation due to increased MG intraprocedurally. Baseline MG and 3D-guided mitral valve area (MVA) by planimetry were retrospectively available in 233 and 109 patients. RESULTS: (71% vs. 16%), baseline MG ≥4 mmHg (61% vs. 20%), or multiple clips implanted (33% vs. 21%, p = 0.04). Increased post-MVTEER MG was associated with increased subsequent mortality compared to those with normal gradient (HR 1.91 95% CI 1.15-3.18 p = 0.016) as was aborted clip insertion compared to all others (HR 5.23 95% CI 2.06-13.28 p < 0.001). CONCLUSIONS: Smaller baseline MVA and increased baseline MG are associated with increased MG post-MVTEER and patients with a Doppler-derived post-MVTEER MG >5 mmHg suffered excess subsequent mortality. In high risk patients considered for MVTEER, identification of those at risk of iatrogenic mitral stenosis with MVTEER is important as they may be optimally treated with alternate surgical or transcatheter therapies.
No takes yet. Share an insight, caveat, or question.
Oğuz et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: